Gina Massa Mias
Responsabile della Conformità presso ESBATech, a Novartis Co. GmbH
Profilo
Ms. Gina M.
Mias is a Principal at Novartis AG and Head-Finance & Compliance Officer at ESBATech AG.
She received her undergraduate degree from the University of Massachusetts and an MBA from the University of Massachusetts.
Posizioni attive di Gina Massa Mias
| Società | Posizione | Inizio |
|---|---|---|
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Responsabile della Conformità | - |
Precedenti posizioni note di Gina Massa Mias
| Società | Posizione | Fine |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | - |
Formazione di Gina Massa Mias
| University of Massachusetts | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Aziende private | 1 |
|---|---|
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Gina Massa Mias
